Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Supernus Pharmaceuticals
(SUPN) Q2 2024
Earnings
SUPN
May 8
Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.29
-0.01
0.28
0.56
Details
Expected EPS
0.2625
Actual EPS
0
Surprise EPS
-0.26
Surprise Percent
-100%
Description
Supernus Pharmaceuticals (SUPN) has reported earnings of 0 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login